Use of valsartan or its metabolite to inhibit platelet aggregation

Details for Australian Patent Application No. 2003267447 (hide)

International Classifications

Event Publications

8 January 2004 Complete Application Filed

Priority application(s): 60/395,014 11.07.02 US; 60/380,373 14.05.02 US

15 January 2004 Application Open to Public Inspection

Published as AU-B-2003267447

26 October 2006 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of valsartan or its metabolite to inhibit platelet aggregation

2 November 2006 Application Accepted

Published as AU-B-2003267447

1 March 2007 Standard Patent Sealed

6 August 2009 Corrigenda

Applications Accepted - Name Index Under the name Novartis AG, Application No. 2003267447, under INID (43) correct the Publication Date to read 24 November 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.